Create

Sign in to ReadmeX

or

How we handle your data: Privacy Policy

ReadmeX

Your AI reading companion

What would you like to catch up on?

Pick a briefing, or ask your own question.

Your community and people briefings stay personal to you.

Story

Brava Security Raises $15M for AI Security Telemetry Platform

AI summary

Brava Security has emerged from stealth with a $15 million seed round led by F2 Venture Capital and Pitango VC, according to The Next Web. Its multi-agent AI platform models attack behavior to generate telemetry without executing attacks, identify detection blind spots, and assess whether existing defenses would recognize an attack. The company says the platform works with Splunk, Google SecOps, CrowdStrike, and more than 70 other sources and destinations.

In-depth insight

Brava Security’s financing highlights a focus on the telemetry and detection evidence that AI security agents need before they can investigate threats effectively.

Brava secures $15M to help security teams find threats their systems miss
Brava Security co-founders Idan Basre and Itay Gabbay. Credit: Brava Security
Image Credits
Brava Security co-founders Idan Basre and Itay Gabbay. Credit: Brava Security

Artificial intelligence is changing how enterprises approach cybersecurity, particularly within security operations centers. The promise is straightforward. AI agents can analyze alerts, investigate suspicious activity, and help security teams respond with greater efficiency.

But the technology depends on something that people often take for granted: reliable security telemetry.

An organization’s security infrastructure may fail to collect the relevant logs, or its detection rules may overlook an attack. Then there may be no alert for an AI agent to investigate. The problem is not necessarily the intelligence of the agent. It is the absence of evidence.

#Brava Security#F2 Venture Capital#Pitango VC#Splunk#Google SecOps#CrowdStrike#Cushman & Wakefield#WELL Health

Original · 5 min readRead the original
Group chat

No comments yet. Start the conversation.